(Q3)Sep 30, 2021 | (FY)Dec 31, 2020 | |
---|---|---|
Operating Cash Flow (Indirect Method) | ||
Cash flow from continuing operating activities | -18.46M | -3.6M |
Net income from continuing operations | ---167.99M | ---14.02M |
Operating gains losses | --24.38M | --955K |
Depreciation and amortization | --1.51M | --4.78M |
Other non cash items | --99.19M | --219K |
Change In working capital | ---7.02M | --1.12M |
-Change in receivables | ---3.18M | ---3.26M |
-Change in inventory | ---1.37M | ---1.73M |
-Change in prepaid assets | ---6.43M | ---1.11M |
-Change in payables and accrued expense | --3.4M | --616K |
-Change in other current liabilities | ---- | --4.09M |
-Change in other working capital | --1.48M | --2.52M |
Cash from discontinued investing activities | ||
Operating cash flow | ---18.46M | ---3.6M |
Investing cash flow | ||
Cash flow from continuing investing activities | -468.65M | -4.88M |
Capital expenditure reported | ---1.98M | ---4.85M |
Net PPE purchase and sale | ---210K | ---30K |
Net investment purchase and sale | ---466.47M | ---- |
Cash from discontinued investing activities | ||
Investing cash flow | ---468.65M | ---4.88M |
Financing cash flow | ||
Cash flow from continuing financing activities | 593.92M | 50.46M |
Net issuance payments of debt | ---10.68M | --6.71M |
Net common stock issuance | ---- | ---438K |
Net preferred stock issuance | ---- | --43.69M |
Proceeds from stock option exercised by employees | --354K | --582K |
Net other financing activities | --604.25M | ---81K |
Cash from discontinued financing activities | ||
Financing cash flow | --593.92M | --50.46M |
Net cash flow | ||
Beginning cash position | --42.68M | --10.15M |
Current changes in cash | --106.81M | --41.98M |
Effect of exchange rate changes | ---169K | --117K |
End cash Position | --149.32M | --52.25M |
Free cash flow | ---20.65M | ---8.48M |
Currency Unit | USD | USD |
Accounting Standards | US-GAAP | US-GAAP |
No Data
No Data